HERBALIFE LTD's ticker is HLF and the CUSIP is G4412G101. A total of 255 filers reported holding HERBALIFE LTD in Q2 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,261,121 | -16.0% | 376,063 | -20.5% | 0.01% | -16.7% |
| Q2 2023 | $6,264,903 | +195.9% | 473,180 | +259.8% | 0.01% | +200.0% |
| Q1 2023 | $2,117,150 | -59.8% | 131,500 | -62.8% | 0.00% | -66.7% |
| Q4 2022 | $5,262,491 | +277.8% | 353,662 | +405.2% | 0.01% | +200.0% |
| Q3 2022 | $1,393,000 | -49.5% | 70,000 | -48.2% | 0.00% | -33.3% |
| Q2 2022 | $2,761,000 | -18.9% | 135,023 | +20.5% | 0.00% | 0.0% |
| Q1 2022 | $3,403,000 | -93.8% | 112,083 | -91.7% | 0.00% | -93.3% |
| Q4 2021 | $54,947,000 | +4264.3% | 1,342,460 | +4420.1% | 0.04% | +4400.0% |
| Q3 2021 | $1,259,000 | +29.5% | 29,700 | +61.1% | 0.00% | 0.0% |
| Q2 2021 | $972,000 | -92.3% | 18,433 | -93.5% | 0.00% | -91.7% |
| Q1 2021 | $12,635,000 | -83.3% | 284,825 | -81.9% | 0.01% | -82.4% |
| Q4 2020 | $75,529,000 | +10.1% | 1,571,887 | +6.9% | 0.07% | -2.9% |
| Q3 2020 | $68,593,000 | +1846.5% | 1,470,381 | +1776.5% | 0.07% | +1650.0% |
| Q2 2020 | $3,524,000 | -91.7% | 78,359 | -94.6% | 0.00% | -94.0% |
| Q1 2020 | $42,663,000 | -71.5% | 1,463,054 | -53.4% | 0.07% | -60.8% |
| Q4 2019 | $149,624,000 | -5.1% | 3,138,763 | -24.7% | 0.17% | -11.9% |
| Q3 2019 | $157,739,000 | -15.6% | 4,166,392 | -4.7% | 0.19% | -16.7% |
| Q2 2019 | $186,910,000 | -42.0% | 4,371,154 | -28.1% | 0.23% | -44.0% |
| Q1 2019 | $322,336,000 | -24.3% | 6,082,949 | -15.8% | 0.42% | -29.1% |
| Q4 2018 | $426,061,000 | +18.2% | 7,227,508 | +9.4% | 0.59% | +35.6% |
| Q3 2018 | $360,428,000 | +26.6% | 6,607,289 | +24.7% | 0.43% | +16.4% |
| Q2 2018 | $284,680,000 | +32.1% | 5,299,326 | +139.7% | 0.37% | +27.0% |
| Q1 2018 | $215,480,000 | -16.7% | 2,210,727 | -42.1% | 0.29% | -17.9% |
| Q4 2017 | $258,639,000 | +38.1% | 3,819,238 | +38.4% | 0.36% | +24.0% |
| Q3 2017 | $187,242,000 | -2.6% | 2,760,466 | +2.4% | 0.29% | -9.4% |
| Q2 2017 | $192,301,000 | +23.9% | 2,695,938 | +1.0% | 0.32% | +16.5% |
| Q1 2017 | $155,255,000 | +24.3% | 2,670,373 | +2.9% | 0.27% | +28.8% |
| Q4 2016 | $124,901,000 | -9.4% | 2,594,540 | +16.6% | 0.21% | -12.8% |
| Q3 2016 | $137,913,000 | -26.2% | 2,224,762 | -30.3% | 0.24% | -29.6% |
| Q2 2016 | $186,816,000 | -9.9% | 3,191,798 | -5.3% | 0.34% | -7.3% |
| Q1 2016 | $207,427,000 | +301.2% | 3,369,504 | +249.4% | 0.37% | +383.1% |
| Q4 2015 | $51,703,000 | +71.8% | 964,243 | +74.6% | 0.08% | +75.0% |
| Q3 2015 | $30,095,000 | -53.4% | 552,186 | -52.9% | 0.04% | -54.2% |
| Q2 2015 | $64,619,000 | -13.5% | 1,172,975 | -32.8% | 0.10% | -15.8% |
| Q1 2015 | $74,686,000 | -53.0% | 1,746,609 | -58.5% | 0.11% | -44.1% |
| Q4 2014 | $158,848,000 | -11.7% | 4,213,470 | +2.5% | 0.20% | -12.4% |
| Q3 2014 | $179,844,000 | +1975.5% | 4,110,715 | +2961.8% | 0.23% | +2018.2% |
| Q2 2014 | $8,665,000 | -91.6% | 134,257 | -92.6% | 0.01% | -92.5% |
| Q1 2014 | $103,388,000 | +20.2% | 1,805,268 | +65.1% | 0.15% | +25.6% |
| Q4 2013 | $86,029,000 | -12.7% | 1,093,127 | -22.6% | 0.12% | -25.5% |
| Q3 2013 | $98,585,000 | +2.4% | 1,413,011 | -33.7% | 0.16% | -13.3% |
| Q2 2013 | $96,234,000 | – | 2,131,892 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BlueDrive Global Investors LLP | 850,028 | $25,807,000 | 11.41% |
| Alua Capital Management LP | 5,353,223 | $162,524,000 | 11.12% |
| Route One Investment Company, L.P. | 10,043,232 | $304,913,000 | 9.50% |
| Bronte Capital Management Pty Ltd. | 2,962,635 | $89,946,000 | 7.56% |
| WINDACRE PARTNERSHIP LLC | 10,003,500 | $303,706,000 | 6.38% |
| CAS Investment Partners, LLC | 2,907,762 | $88,280,000 | 5.91% |
| Deccan Value Investors L.P. | 3,062,839 | $92,988,000 | 4.74% |
| JABODON PT CO | 170,332 | $5,171,000 | 2.35% |
| 683 Capital Management, LLC | 1,440,597 | $43,737,000 | 2.34% |
| Patient Capital Management, LLC | 194,300 | $5,899,000 | 2.00% |